kaal:position:2026-07-31-4459

LSD2/KDM1B and Its Cofactor NPAC/GLYR1 Endow a Structural and Molecular Model for Regulation of H3K4 Demethylation should be assessed against Kaal's source-bound claim that Based on these findings, adviser size may not matter as much for policy adjustments and SEC rule making as the hedge fund industry and its representatives have claimed. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

SEC rule making under Title IV
policy adjustments keyed to adviser size
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

LSD2/KDM1B and Its Cofactor NPAC/GLYR1 Endow a Structural and Molecular Model for Regulation of H3K4 Demethylation

Scholarly basis

kaal:claim:2389423-011
Wulf A. Kaal, The Impact of Dodd-Frank Act Compliance Cost on the Hedge Fund Industry (2014). SSRN: https://ssrn.com/abstract=2389423
Source PDF sha256: 6b95323abbaffd00a012589531859f2938ab8b372d0243171059ff82e55a0838

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2181
Mapping ambiguous: true

Topics

dynamic-regulationsecurities-law

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0018 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 2ed2f24c6c22242f545c06cee28d421a146802454fbb6ddbab7e6636f0295343
curl -s https://wulfkaal.github.io/positions/2026-07-31-4459.md | sha256sum